FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3009278340> ?p ?o ?g. }

• W3009278340 endingPage "1985" @default.
• W3009278340 startingPage "1976" @default.
• W3009278340 abstract "CD147 has emerged as a potential therapeutic target in many human diseases. We have demonstrated that inhibition of CD147 using its function-blocking antibody ameliorates acute ischemic brain injury and promotes long-term functional recovery in mice. Recently, peptide–nanoparticle conjugates have emerged as powerful tools for biomedical applications. The present study aimed to investigate the therapeutic potential of CD147 antagonist peptide-9 (AP9) in acute ischemic stroke in mice using nanomaterial as the drug delivery vehicles. AP9-conjugated nanoparticles (APN), with an average size of about 40 nm, were fabricated by maleimide linkage and characterized using dynamic light scattering and transmission electron microscopy. We found that APN specifically bound to CD147 in cultured mouse brain endothelial cells (bEnd.3) and to ischemia-induced CD147 in mouse cerebral microvessels. Using a mouse model of transient middle cerebral artery occlusion (tMCAO), we demonstrated, for the first time, that systemic delivery of APN (2.5 mg/kg, I.V.) initiated at 1 h after tMCAO significantly reduced brain infarct size, improved functional outcome, and attenuated delayed (5 h after tMCAO) tPA-induced intracerebral hemorrhage in acute ischemic stroke. These protective effects were associated with profound inhibition of MMP-9 and MMP-3 in both ischemic brain and plasma. In conclusion, the CD147 antagonist peptide-9 represents a potentially promising therapeutic candidate for the treatment of ischemic stroke." @default.
• W3009278340 created "2020-03-13" @default.
• W3009278340 creator A5013873075 @default.
• W3009278340 creator A5015102287 @default.
• W3009278340 creator A5082496274 @default.
• W3009278340 creator A5083726097 @default.
• W3009278340 date "2020-03-03" @default.
• W3009278340 modified "2023-10-14" @default.
• W3009278340 title "Nanoparticle Delivery of CD147 Antagonistic Peptide-9 Protects against Acute Ischemic Brain Injury and tPA-Induced Intracerebral Hemorrhage in Mice" @default.
• W3009278340 cites W1519720742 @default.
• W3009278340 cites W1580407891 @default.
• W3009278340 cites W1976017263 @default.
• W3009278340 cites W2010410884 @default.
• W3009278340 cites W2014848130 @default.
• W3009278340 cites W2016124510 @default.
• W3009278340 cites W2022130383 @default.
• W3009278340 cites W2027549866 @default.
• W3009278340 cites W2034049989 @default.
• W3009278340 cites W2049144486 @default.
• W3009278340 cites W2056553691 @default.
• W3009278340 cites W2061066482 @default.
• W3009278340 cites W2063544001 @default.
• W3009278340 cites W2077426548 @default.
• W3009278340 cites W2096316234 @default.
• W3009278340 cites W2102311691 @default.
• W3009278340 cites W2119007498 @default.
• W3009278340 cites W2122866927 @default.
• W3009278340 cites W2125683177 @default.
• W3009278340 cites W2127123729 @default.
• W3009278340 cites W2128465219 @default.
• W3009278340 cites W2130190017 @default.
• W3009278340 cites W2131303775 @default.
• W3009278340 cites W2135237475 @default.
• W3009278340 cites W2158203528 @default.
• W3009278340 cites W2160213908 @default.
• W3009278340 cites W2197053162 @default.
• W3009278340 cites W2238824845 @default.
• W3009278340 cites W2252683637 @default.
• W3009278340 cites W2275603548 @default.
• W3009278340 cites W2280193287 @default.
• W3009278340 cites W2324055247 @default.
• W3009278340 cites W2558801358 @default.
• W3009278340 cites W2588320052 @default.
• W3009278340 cites W2593726173 @default.
• W3009278340 cites W2756780332 @default.
• W3009278340 cites W2766425483 @default.
• W3009278340 cites W2767859172 @default.
• W3009278340 cites W2803718019 @default.
• W3009278340 cites W2805576434 @default.
• W3009278340 cites W2884979251 @default.
• W3009278340 cites W2887050230 @default.
• W3009278340 cites W2901086519 @default.
• W3009278340 cites W2901163162 @default.
• W3009278340 cites W2905349521 @default.
• W3009278340 cites W2928652884 @default.
• W3009278340 cites W2952293990 @default.
• W3009278340 cites W2964243956 @default.
• W3009278340 cites W2966301712 @default.
• W3009278340 cites W4296234323 @default.
• W3009278340 doi "https://doi.org/10.1021/acsabm.9b01141" @default.
• W3009278340 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8195622" @default.
• W3009278340 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34124605" @default.
• W3009278340 hasPublicationYear "2020" @default.
• W3009278340 type Work @default.
• W3009278340 sameAs 3009278340 @default.
• W3009278340 citedByCount "5" @default.
• W3009278340 countsByYear W30092783402020 @default.
• W3009278340 countsByYear W30092783402021 @default.
• W3009278340 countsByYear W30092783402022 @default.
• W3009278340 countsByYear W30092783402023 @default.
• W3009278340 crossrefType "journal-article" @default.
• W3009278340 hasAuthorship W3009278340A5013873075 @default.
• W3009278340 hasAuthorship W3009278340A5015102287 @default.
• W3009278340 hasAuthorship W3009278340A5082496274 @default.
• W3009278340 hasAuthorship W3009278340A5083726097 @default.
• W3009278340 hasBestOaLocation W30092783402 @default.
• W3009278340 hasConcept C126322002 @default.
• W3009278340 hasConcept C127413603 @default.
• W3009278340 hasConcept C2777094939 @default.
• W3009278340 hasConcept C2777736543 @default.
• W3009278340 hasConcept C2780645631 @default.
• W3009278340 hasConcept C42219234 @default.
• W3009278340 hasConcept C541997718 @default.
• W3009278340 hasConcept C71924100 @default.
• W3009278340 hasConcept C78519656 @default.
• W3009278340 hasConcept C98274493 @default.
• W3009278340 hasConceptScore W3009278340C126322002 @default.
• W3009278340 hasConceptScore W3009278340C127413603 @default.
• W3009278340 hasConceptScore W3009278340C2777094939 @default.
• W3009278340 hasConceptScore W3009278340C2777736543 @default.
• W3009278340 hasConceptScore W3009278340C2780645631 @default.
• W3009278340 hasConceptScore W3009278340C42219234 @default.
• W3009278340 hasConceptScore W3009278340C541997718 @default.
• W3009278340 hasConceptScore W3009278340C71924100 @default.
• W3009278340 hasConceptScore W3009278340C78519656 @default.
• W3009278340 hasConceptScore W3009278340C98274493 @default.
• W3009278340 hasFunder F4320337359 @default.
• W3009278340 hasIssue "4" @default.

• next